Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
37.16B | 38.63B | 35.95B | 32.57B | 27.72B | 20.40B | Gross Profit |
19.96B | 22.34B | 17.86B | 18.56B | 15.81B | 11.39B | EBIT |
7.22B | 7.55B | 7.01B | 5.52B | 4.28B | 1.51B | EBITDA |
10.36B | 11.10B | 9.97B | 8.22B | 7.10B | 4.24B | Net Income Common Stockholders |
5.64B | 5.87B | 5.38B | 4.13B | 3.24B | 1.11B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
11.49B | 11.50B | 11.42B | 10.08B | 9.39B | 7.57B | Total Assets |
34.09B | 34.71B | 32.73B | 29.98B | 28.95B | 26.42B | Total Debt |
5.49B | 7.13M | 5.74B | 5.60B | 6.01B | 6.35B | Net Debt |
-2.45B | -6.38B | -1.27B | 35.00M | -1.01B | -1.05B | Total Liabilities |
16.70B | 15.04B | 14.06B | 12.95B | 13.19B | 11.87B | Stockholders Equity |
17.36B | 19.68B | 18.64B | 17.01B | 15.73B | 14.52B |
Cash Flow | Free Cash Flow | ||||
1.48B | 6.62B | 6.80B | 5.26B | 5.63B | 2.31B | Operating Cash Flow |
1.48B | 9.29B | 8.67B | 6.67B | 6.75B | 3.02B | Investing Cash Flow |
0.00 | -3.29B | -1.71B | -3.50B | -3.25B | 2.51B | Financing Cash Flow |
0.00 | -6.61B | -5.47B | -4.61B | -3.91B | -2.79B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
84 Outperform | $40.55B | 22.42 | 42.42% | ― | 10.07% | 19.40% | |
80 Outperform | $170.55B | 26.94 | 31.07% | 2.20% | 6.78% | 8.62% | |
78 Outperform | $150.65B | 31.68 | 60.36% | 1.11% | 3.79% | ― | |
73 Outperform | $10.53B | 12.72 | 28.81% | 2.22% | 1.32% | 65.83% | |
73 Outperform | $50.73B | 24.42 | 40.28% | 0.98% | 3.69% | 13.71% | |
70 Outperform | $16.89B | 33.14 | 42.55% | ― | 9.33% | 50.05% | |
62 Neutral | $6.97B | 11.36 | 2.77% | 3.91% | 2.66% | -22.00% |